BBC Home
BBC Home
Ready to play
Ready to play
The article discusses the rise of illegal counterfeit versions of the experimental weight-loss drug retatrutide, which is still undergoing clinical trials and has not been approved for general use. These fake products are flooding the black market, with individuals purchasing and using unverified substances that pose serious health risks, including overdose and hospitalization. Experts emphasize the dangers of illicit retatrutide, as it may contain unknown ingredients and contaminants, and warn that the genuine drug targets three hormones to promote weight loss, unlike current market options. Regulatory authorities are actively trying to combat illegal sales, but the availability of fake versions remains a significant concern.
Notice: This Is an AI-Generated Summary
Comments (0)